Last CNY21.91 CNY
Change Today +0.06 / 0.27%
Volume 1.2M
600511 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

china national medicines-a (600511) Snapshot

Open
CNY21.95
Previous Close
CNY21.85
Day High
CNY22.20
Day Low
CNY21.60
52 Week High
02/18/14 - CNY25.20
52 Week Low
07/19/13 - CNY14.91
Market Cap
10.5B
Average Volume 10 Days
1.5M
EPS TTM
CNY0.90
Shares Outstanding
478.8M
EX-Date
06/19/14
P/E TM
24.4x
Dividend
CNY0.26
Dividend Yield
1.19%
Current Stock Chart for CHINA NATIONAL MEDICINES-A (600511)

Related News

No related news articles were found.

china national medicines-a (600511) Related Businessweek News

No Related Businessweek News Found

china national medicines-a (600511) Details

China National Medicines Corporation Ltd. is engaged in the distribution of pharmaceutical products in China. It is involved in the wholesale of Chinese patent drugs, chemical preparations, chemical bulk drugs, antibiotics, biochemical products, biological products, stupefacient products, psychotropic substances and vaccines, and other products, as well as distribution of health foods. The company also provides logistics services. It operates primarily in Huainan, Anhui Province, and Beijing. China National Medicines Corporation Ltd. was founded in 1999 and is based in Beijing, China.

Founded in 1999

china national medicines-a (600511) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

china national medicines-a (600511) Key Developments

China National Medicines Corporation Ltd., Board Meeting, May 28, 2014

China National Medicines Corporation Ltd., Board Meeting, May 28, 2014. Agenda: To discuss and approve the proposal of changing the bank providing entrusted loan to holding subsidiary Sino-pharm Logistics Co., Ltd. for 2014.

China National Medicines Corporation Ltd. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2014

China National Medicines Corporation Ltd. reported unaudited earnings results for the first quarter ended March 31, 2014. For the quarter, the operating income was RMB 2,704,890,874.74 against RMB 2,378,139,113.92 a year ago. Net profit attributable to shareholders of the listed company was RMB 102,018,862.05 against RMB 82,612,200.08 a year ago. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was RMB 101,968,284.42 against RMB 82,578,391.81 a year ago. Weighted average return on net assets was 4.73% against 4.49% a year ago. Earnings Basic and diluted per share were RMB 0.2131 against RMB 0.1725 a year ago. Net cash flow arising from operating activities was RMB 55,621,943.85 against RMB 37,020,982.12 a year ago.

China National Medicines Corporation Ltd. to Report Q1, 2014 Results on Apr 26, 2014

China National Medicines Corporation Ltd. announced that they will report Q1, 2014 results on Apr 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600511:CH CNY21.91 CNY +0.06

600511 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600511.
View Industry Companies
 

Industry Analysis

600511

Industry Average

Valuation 600511 Industry Range
Price/Earnings 24.4x
Price/Sales 1.0x
Price/Book 4.8x
Price/Cash Flow 24.4x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA NATIONAL MEDICINES-A, please visit www.cncm.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.